CrystalsFirst announces its generative AI extension - FragAI - as part of the MAGNET platform.

CrystalsFirst’s MAGNET platform overcomes current limitations of small molecule drug discovery. Our proprietary technology SmartSoak® detects molecular magnets and generative AI identifies novel molecules and druggable binding pockets. 

Applications and features of FragAI: 

  • Intellectual Property shield and protection
  • Ligand- and structure-based workflows
  • Fragment evolution for FBDD
  • Hit-to-lead and lead optimization tailoring the target product profile
  • Compatible with X-ray crystallography and CryoEM derived structures

Subscribe to stay tuned